Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity

Serology is an important way to monitor SARS-CoV-2 infection in the population and support vaccine development. Here the authors develop a multiplex immunoassay including spike and nucleocapsid proteins of SARS-CoV-2 and the endemic human coronaviruses with high specificity and sensitivity.

Guardado en:
Detalles Bibliográficos
Autores principales: Matthias Becker, Monika Strengert, Daniel Junker, Philipp D. Kaiser, Tobias Kerrinnes, Bjoern Traenkle, Heiko Dinter, Julia Häring, Stéphane Ghozzi, Anne Zeck, Frank Weise, Andreas Peter, Sebastian Hörber, Simon Fink, Felix Ruoff, Alex Dulovic, Tamam Bakchoul, Armin Baillot, Stefan Lohse, Markus Cornberg, Thomas Illig, Jens Gottlieb, Sigrun Smola, André Karch, Klaus Berger, Hans-Georg Rammensee, Katja Schenke-Layland, Annika Nelde, Melanie Märklin, Jonas S. Heitmann, Juliane S. Walz, Markus Templin, Thomas O. Joos, Ulrich Rothbauer, Gérard Krause, Nicole Schneiderhan-Marra
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/873a2271e3d141e88ecbd175b0df6297
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:873a2271e3d141e88ecbd175b0df6297
record_format dspace
spelling oai:doaj.org-article:873a2271e3d141e88ecbd175b0df62972021-12-02T10:52:47ZExploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity10.1038/s41467-021-20973-32041-1723https://doaj.org/article/873a2271e3d141e88ecbd175b0df62972021-02-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-20973-3https://doaj.org/toc/2041-1723Serology is an important way to monitor SARS-CoV-2 infection in the population and support vaccine development. Here the authors develop a multiplex immunoassay including spike and nucleocapsid proteins of SARS-CoV-2 and the endemic human coronaviruses with high specificity and sensitivity.Matthias BeckerMonika StrengertDaniel JunkerPhilipp D. KaiserTobias KerrinnesBjoern TraenkleHeiko DinterJulia HäringStéphane GhozziAnne ZeckFrank WeiseAndreas PeterSebastian HörberSimon FinkFelix RuoffAlex DulovicTamam BakchoulArmin BaillotStefan LohseMarkus CornbergThomas IlligJens GottliebSigrun SmolaAndré KarchKlaus BergerHans-Georg RammenseeKatja Schenke-LaylandAnnika NeldeMelanie MärklinJonas S. HeitmannJuliane S. WalzMarkus TemplinThomas O. JoosUlrich RothbauerGérard KrauseNicole Schneiderhan-MarraNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Matthias Becker
Monika Strengert
Daniel Junker
Philipp D. Kaiser
Tobias Kerrinnes
Bjoern Traenkle
Heiko Dinter
Julia Häring
Stéphane Ghozzi
Anne Zeck
Frank Weise
Andreas Peter
Sebastian Hörber
Simon Fink
Felix Ruoff
Alex Dulovic
Tamam Bakchoul
Armin Baillot
Stefan Lohse
Markus Cornberg
Thomas Illig
Jens Gottlieb
Sigrun Smola
André Karch
Klaus Berger
Hans-Georg Rammensee
Katja Schenke-Layland
Annika Nelde
Melanie Märklin
Jonas S. Heitmann
Juliane S. Walz
Markus Templin
Thomas O. Joos
Ulrich Rothbauer
Gérard Krause
Nicole Schneiderhan-Marra
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
description Serology is an important way to monitor SARS-CoV-2 infection in the population and support vaccine development. Here the authors develop a multiplex immunoassay including spike and nucleocapsid proteins of SARS-CoV-2 and the endemic human coronaviruses with high specificity and sensitivity.
format article
author Matthias Becker
Monika Strengert
Daniel Junker
Philipp D. Kaiser
Tobias Kerrinnes
Bjoern Traenkle
Heiko Dinter
Julia Häring
Stéphane Ghozzi
Anne Zeck
Frank Weise
Andreas Peter
Sebastian Hörber
Simon Fink
Felix Ruoff
Alex Dulovic
Tamam Bakchoul
Armin Baillot
Stefan Lohse
Markus Cornberg
Thomas Illig
Jens Gottlieb
Sigrun Smola
André Karch
Klaus Berger
Hans-Georg Rammensee
Katja Schenke-Layland
Annika Nelde
Melanie Märklin
Jonas S. Heitmann
Juliane S. Walz
Markus Templin
Thomas O. Joos
Ulrich Rothbauer
Gérard Krause
Nicole Schneiderhan-Marra
author_facet Matthias Becker
Monika Strengert
Daniel Junker
Philipp D. Kaiser
Tobias Kerrinnes
Bjoern Traenkle
Heiko Dinter
Julia Häring
Stéphane Ghozzi
Anne Zeck
Frank Weise
Andreas Peter
Sebastian Hörber
Simon Fink
Felix Ruoff
Alex Dulovic
Tamam Bakchoul
Armin Baillot
Stefan Lohse
Markus Cornberg
Thomas Illig
Jens Gottlieb
Sigrun Smola
André Karch
Klaus Berger
Hans-Georg Rammensee
Katja Schenke-Layland
Annika Nelde
Melanie Märklin
Jonas S. Heitmann
Juliane S. Walz
Markus Templin
Thomas O. Joos
Ulrich Rothbauer
Gérard Krause
Nicole Schneiderhan-Marra
author_sort Matthias Becker
title Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
title_short Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
title_full Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
title_fullStr Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
title_full_unstemmed Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity
title_sort exploring beyond clinical routine sars-cov-2 serology using multicov-ab to evaluate endemic coronavirus cross-reactivity
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/873a2271e3d141e88ecbd175b0df6297
work_keys_str_mv AT matthiasbecker exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT monikastrengert exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT danieljunker exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT philippdkaiser exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT tobiaskerrinnes exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT bjoerntraenkle exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT heikodinter exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT juliaharing exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT stephaneghozzi exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT annezeck exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT frankweise exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT andreaspeter exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT sebastianhorber exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT simonfink exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT felixruoff exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT alexdulovic exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT tamambakchoul exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT arminbaillot exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT stefanlohse exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT markuscornberg exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT thomasillig exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT jensgottlieb exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT sigrunsmola exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT andrekarch exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT klausberger exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT hansgeorgrammensee exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT katjaschenkelayland exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT annikanelde exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT melaniemarklin exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT jonassheitmann exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT julianeswalz exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT markustemplin exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT thomasojoos exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT ulrichrothbauer exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT gerardkrause exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
AT nicoleschneiderhanmarra exploringbeyondclinicalroutinesarscov2serologyusingmulticovabtoevaluateendemiccoronaviruscrossreactivity
_version_ 1718396542825529344